🔴 Decoy Therapeutics is trading 5.68% down today amid biotech weakness as XBI fell 2.06%

Decoy Therapeutics is trading at $1.16, down 5.68%, amid biotech-sector weakness.

• No confirmed company-specific announcement explaining the October 16 decline surfaced in available search results; the company’s recent preclinical update dates to September 29.
• Supplied market data shows XBI down 2.06%, while broader indexes are also lower; biotech investors have retreated from the sector’s August highs.
• The move is consistent with broader risk-off sentiment, but no Decoy Therapeutics-specific catalyst was identified.